Serum ammonia as a non-invasive marker for early prediction of esophageal varices.
Journal
European journal of gastroenterology & hepatology
ISSN: 1473-5687
Titre abrégé: Eur J Gastroenterol Hepatol
Pays: England
ID NLM: 9000874
Informations de publication
Date de publication:
01 02 2021
01 02 2021
Historique:
pubmed:
4
4
2020
medline:
3
8
2021
entrez:
4
4
2020
Statut:
ppublish
Résumé
There is a growing need for identification of non-endoscopic, non-invasive methods that can accurately predict esophageal varices (EV). Previous studies found an inconclusive correlation between blood ammonia level and the presence and size of EV. We aimed at assessing the value of serum ammonia as a non-invasive method for early prediction of EV. The study included 204 patients with HCV-related cirrhosis. The selected patients were categorized into two groups: patients with EV and those without, also patients with no or small EV and with large EV group. All patients underwent a complete biochemical workup, ultrasound and upper GI endoscopy. Child-Pugh class, Model of End-Stage Liver Disease (MELD) score and platelet count/splenic diameter ratio, and serum ammonia level. There was a statistical difference between the two groups of patients regarding the following parameters: serum ammonia, international normalized ratio, portal vein diameter, spleen diameter, Child-Pugh class, MELD score, platelet count/splenic diameter ratio, aspartate aminotransferase-to-platelet ratio index, alanine aminotransferase-to-aspartate aminotransferase ratio, Forns index, FIB-4 and King's score. Serum ammonia could predict the presence of EV using a cutoff value of 82 (µmol/L) with a sensitivity of 92.3%, specificity 92%. In addition, a cutoff of 95.5 (µmol/L) could predict large EV with a sensitivity of 92.7% and a specificity of 92.3%. Serum Ammonia in cirrhosis with large EV was 143 ± 39 µmol/L and in cirrhosis with small/without EV was 80.7 ± 9.7 µmol/L (P < 0.0001). Platelet/spleen ratio was 555.9 ± 187.3 in cirrhosis with EV and 694.4 ± 74.2 in cirrhosis without EV (P < 0.0001). Platelet/spleen ratio was 407.7 ± 107.1 in cirrhosis with large EV and 690.4 ± 103.7 in cirrhosis with small/without EV (P < 0.0001). Serum ammonia can accurately predict the presence and the size of EV in patients with liver cirrhosis with high sensitivity and specificity.
Identifiants
pubmed: 32243345
pii: 00042737-202102000-00015
doi: 10.1097/MEG.0000000000001715
doi:
Substances chimiques
Ammonia
7664-41-7
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
230-236Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Références
Maruyama H, Yokosuka O. Pathophysiology of portal hypertension and esophageal varices. Int J Hepatol. 2012; 2012:895787.
de Franchis R; Baveno VI Faculty. Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015; 63:743–752.
Merli M, Nicolini G, Angeloni S, Rinaldi V, De Santis A, Merkel C, et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol. 2003; 38:266–272.
Sun Z, Migaly J. Review of hemorrhoid disease: presentation and management. Clin Colon Rectal Surg. 2016; 29:22–29.
Bloom S, Kemp W, Lubel J. Portal hypertension: pathophysiology, diagnosis and management. Intern Med J. 2015; 45:16–26.
Hassan EA, Abd El-rehim AS, Sayed ZA. Non invasive parameters of oesophageal varices diagnosis: which sensitive and applicable; a pilot study. J Liver. 2015; 4:3
de Franchis R. Developing consensus in portal hypertension. J Hepatol. 1996; 25:390–394.
Peng Y, Qi X, Dai J, Li H, Guo X. Child-pugh versus MELD score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis. Int J Clin Exp Med. 2015; 8:751–757.
Giannini E, Zaman A, Kreil A, Floreani A, Dulbecco P, Testa E, et al. “Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study”. Am J Gastroenterol. 2006; 101:2511–2519.
Castéra L, Bail B, Roudot-Thoraval F, Bernard PH, Foucher J, Merrouche W, et al. “Early detection in routine clinical practice of cirrhosis and esophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores”. J Hepatol. 2009; 50:59–68.
Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003; 38:518–526.
Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology. 2007; 46:32–36.
Forns X, Ampurdanès S, Llovet JM, Aponte J, Quintó L, Martínez-Bauer E, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology. 2002; 36:986–992.
Cross TJ, Rizzi P, Berry PA, Bruce M, Portmann B, Harrison PM. king’s score: an accurate marker of cirrhosis in chronic hepatitis C. Eur J Gastroenterol Hepatol. 2009; 34:331–339.
Tarantino G, Citro V, Esposito P, Giaquinto S, de Leone A, Milan G, et al. Blood ammonia levels in liver cirrhosis: a clue for the presence of portosystemic collateral veins. BMC Gastroenterol. 2009; 9:21.
Lubel JS, Angus PW. Modern management of portal hypertension. Intern Med J. 2005; 35:45–49.
Khondaker M, Ahmad N, Al-Mahtab M. Correlation between blood Ammonia Level and esophageal Varices. Euroasian J Hepato- Gastroenterol. 2013; 3:10–14.
El-Hefeny N, Hareedy M, Abdel –Aal R. Blood ammonia level and other non invasive parameters as indicators of portosystemic collaterals in cirrhotic patients: Thesis submitted for partial fulfillment of MSC degree in internal medicine. Assiute University; 2013.
Montasser M, Abdella H, Samy A. Evaluation of venous ammonia level, splenic longitudinal diameter and portal vein diameter as non invasive indicator for portosystemic collaterals in Egyptian cirrhotic patients. J Gastroenterol. 2014; 4:265–274
Lashin A, El feky H, Elbehisy M. Blood ammonia level: is it a clue for the presence of oesophageal varices in cirrhotic patients?. Afro-Egypt J Infect Endem Dis. 2017; 7:169–671.
Ramzy I, Hafez HA, Madani H. Predictive value of non-invasive blood ammonia level for the presence of oesophageal varices in Egyptian patients with liver cirrhosis. J Gastroenterol Hepatol Res. 2015; 4:1613–1617.
Sarangapani A, Shanmugam C, Kalyanasundaram M, Rangachari B, Thangavelu P, Subbarayan JK. Non invasive prediction of large EV in CLD. Saudi J Gastroenterol. 2010; 16:38–42.
Baig WW, Nagaraja MV, Varma M. spleen diameter for diagnosis of EV.is it feasible?. J Gastroenterol. 2008; 22:852–854
Giannini E, Botta F, Borro P, Risso D, Romagnoli P, Fasoli A, et al. Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut. 2003; 52:1200–1205.
Abo-Alsoud AA, Badawy AM, Sonbol AA. Study of the relationship between blood ammonia level and esophageal varices in patients with liver cirrhosis Afro-Egypt. J Infect Endem Dis. 2015; 5:78–85.
Qamar AA, Grace ND, Groszmann RJ, Garcia-Tsao G, Bosch J, Burroughs AK, et al. Platelet count is not a predictor of the presence or development of Gastroesophageal varices in cirrhosis. Hepatology. 2000; 47: 153–159.
Kraja B, Mone I, Akshija I, Koçollari A, Prifti S, Burazeri G. Predictors of esophageal varices and first variceal bleeding in liver cirrhosis patients. World J Gastroenterol. 2017; 23:4806–4814.
Deng H, Qi X, Guo X. Diagnostic accuracy of APRI, AAR, FIB-4, FI, King, lok, forns, and fibroindex scores in predicting the presence of esophageal varices in liver cirrhosis: a systematic review and meta-analysis. Medicine (Baltimore). 2015; 94:e1795.
Sebastiani G, Tempesta D, Fattovich G, Castera L, Halfon P, Bourliere M, et al. Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: results of a multicenter, large-scale study. J Hepatol. 2010; 53:630–638.